Allostery in disease and in drug discovery.
By Ruth Nussinov, Chung-Jung Tsai. 2013
704 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Anima Anandkumar
- Weili Nie
- Arash Vahdat
- Thomas F. Miller
- Zhuoran Qiao
- Chung-Jung Tsai
- Ruth Nussinov
- Alexandre M. J. J. Bonvin
In Oncology
Citations in the corpus
- State-specific protein–ligand complex structure prediction with a multiscale deep generative model (2022, neutral): “…modulated by small molecules such as ligands and posttranslational modifications 13–16 ; such dynamical conformational changes can trigger diverse downstream responses that are crucial to the regulation of biological functions and with far-reaching implications for drug discovery 14,17–19 .”
- A Unified View of “How Allostery Works” (2014, background): “Third, to figure out an activation event, we suggest considering whether ligand binding at the allosteric site stabilizes the active conformation or destabilizes the inactive conformation or both at the same time [1].”
- Dynamic-Backbone Protein-Ligand Structure Prediction with Multiscale Generative Diffusion Models (2022, methodology): “Protein structures are dynamically modulated by their interactions with small-molecule ligands, triggering downstream responses that are crucial to the regulation of biological functions [1–3].”